Cited by 1,873Pain Mechanisms and TreatmentsPain Management and TreatmentPain Management and Opioid Use

The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

Open access

Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T.·2010·European Journal of Neurology

DOI 10.1111/j.1468-1331.2010.02999.x

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND AND OBJECTIVES: This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005. METHODS: Studies were identified using the Cochrane Database and Medline. Trials were classified according to the aetiological condition. All class I and II randomized controlled trials (RCTs) were assessed; lower class studies were considered only in conditions that had no top-level studies. Treatments administered using repeated or single administrations were considered, provided they are feasible in an outpatient setting. RESULTS: Most large RCTs included patients with diabetic polyneuropathies and post-herpetic neuralgia, while an increasing number of smaller studies explored other conditions. Drugs generally have similar efficacy in various conditions, except in trigeminal neuralgia, chronic radiculopathy and HIV neuropathy, with level A evidence in support of tricyclic antidepressants (TCA), pregabalin, gabapentin, tramadol and opioids (in various conditions), duloxetine, venlafaxine, topical lidocaine and capsaicin patches (in restricted conditions). Combination therapy appears useful for TCA-gabapentin and gabapentin-opioids (level A). CONCLUSIONS: There are still too few large-scale comparative studies. For future trials, we recommend to assess comorbidities, quality of life, symptoms and signs with standardized tools and attempt to better define responder profiles to specific drug treatments.

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2010.02999.x

Cites

236 of 236 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 retracted

Anticonvulsant drugs for acute and chronic pain
Wiffen, P. J., Collins, S., McQuay, H. J., Carroll, D., Jadad, A. R., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001133.pub2 · Cited by 409
Retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J. E., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452 · Cited by 247
Retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J. E., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452.pub2 · Cited by 230
Retracted
Topical lidocaine for the treatment of postherpetic neuralgia
Khaliq, W., Alam, S., & Puri, N. K. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004846.pub2 · Cited by 160
Retracted
Anticonvulsant drugs for acute and chronic pain
Wiffen, P. J., Collins, S., McQuay, H. J., Carroll, D., Jadad, A. R., & Moore, R. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001133.pub3 · Cited by 153
Retracted
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B., Cleeland, C., Dionne, R., Farrar, J. T., Galer, B. S., et al. (2003) · Pain · doi:10.1016/j.pain.2003.08.001 · Cited by 3,510
Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms
Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 3,362
Untitled work
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Self-citation
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126

Show all 236 references

Sorted by citations

Items 301–400 of 1,000

Coping with Phantom Limb Pain
Kuffler, D. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0718-9 · Cited by 52
“Although the role of tricyclic antidepressants is clear for various neuropathic pain conditions, it is not definitive against PLP [31] and tricyclic antidepressants have been shown to fail to effectively control the pain [32, 33].”
Background
Treatment of Neuropathic Pain Directly Due to Cancer: An Update
Shkodra, M., & Caraceni, A. T. (2022) · Cancers · doi:10.3390/cancers14081992 · Cited by 51
Neuroinflammation Involved in Diabetes-Related Pain and Itch
Fang, X.-X., Wang, H., Song, H.-L., Wang, J., & Zhang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.921612 · Cited by 57
Towards a definition of refractory neuropathic pain for epidemiological research. An international Delphi survey of experts
Smith, B. H., Torrance, N., Ferguson, J. A., Bennett, M., Serpell, M. G., & Dunn, K. M. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-29 · Cited by 53
Post-herpetic neuralgia
Parruti, G., Tontodonati, Ursini, T., Polilli, Vadini, & Masi, D. (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s10371 · Cited by 51
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models
Grim, T. W., Ghosh, S., Hsu, K.-L., Cravatt, B. F., Kinsey, S. G., & Lichtman, A. H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.07.008 · Cited by 50
Ameliorative potential of ferulic acid in vincristine-induced painful neuropathy in rats: An evidence of behavioral and biochemical examination
Vashistha, B., Sharma, A., & Jain, V. (2014) · Nutritional Neuroscience · doi:10.1179/1476830514y.0000000165 · Cited by 50
Sacral nerve modulation in the treatment of chronic pelvic pain
Martellucci, J., Naldini, G., & Carriero, A. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1394-2 · Cited by 50
Potentially Inappropriate Medication Use Among Finnish Non-Institutionalized People Aged ≥65 Years
Leikola, S. N. S., Dimitrow, M. S., Lyles, A., Pitkälä, K. H., & Airaksinen, M. S. A. (2011) · Drugs & Aging · doi:10.2165/11586890-000000000-00000 · Cited by 50
Evaluation of surgical treatment for neuropathic pain from neuroma in patients with injured peripheral nerves
Decrouy-Duruz, V., Christen, T., & Raffoul, W. (2017) · Journal of neurosurgery · doi:10.3171/2017.1.jns161778 · Cited by 50
Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey
Bilevicius, E., Sommer, J. L., Asmundson, G. J. G., & El-Gabalawy, R. M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.005 · Cited by 52
Pharmacotherapy to Manage Central Post-Stroke Pain
Choi, H. R., Aktas, A., & Bottros, M. M. (2021) · CNS Drugs · doi:10.1007/s40263-021-00791-3 · Cited by 56
Pharmacotherapy of Neuropathic Pain: Time To Rewrite The Rulebook?
Finnerup, N. B., & Attal, N. (2015) · Pain Management · doi:10.2217/pmt.15.53 · Cited by 51
Self-citation
Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations?
Dworkin, R. H., Panarites, C. J., Armstrong, E. P., Malone, D. C., & Pham, S. V. (2012) · Pain · doi:10.1016/j.pain.2012.01.015 · Cited by 49
Cytokines in Neuropathic Pain and Associated Depression
Lees, J. G., Fivelman, B., Duffy, S. S., Makker, P. G. S., Perera, C. J., & Moalem‐Taylor, G. (2015) · Modern trends in psychiatry · doi:10.1159/000435932 · Cited by 49
Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: Involvement of serotonergic system
Zhao, X., Yu, C., Wang, C., Zhang, J., Zhou, W., Cui, W., Ye, F., & Xu, Y. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.04.021 · Cited by 49
Levetiracetam in patients with central neuropathic post‐stroke pain – a randomized, double‐blind, placebo‐controlled trial
Jungehulsing, G. J., Israel, H., Safar, N., Taskin, B., Nolte, C. H., Brunecker, P., Wernecke, K. ‐., & Villringer, A. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03857.x · Cited by 49
Fulranumab for treatment of diabetic peripheral neuropathic pain
Wang, H., Romano, G. J., Frustaci, M. E., Bohidar, N., Ma, H., Sanga, P., Ness, S. L., Russell, L. J., Fedgchin, M., Kelly, K. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000686 · Cited by 49
Pain assessment according to the International Spinal Cord Injury Pain classification in patients with spinal cord injury referred to a multidisciplinary pain center
Mahnig, S., Landmann, G., Stockinger, L., & Opsommer, E. (2016) · Spinal Cord · doi:10.1038/sc.2015.219 · Cited by 49
Painful Traumatic Trigeminal Neuropathy
Benoliel, R., Teich, S., & Eliav, E. (2016) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2016.03.002 · Cited by 49
Homology‐guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2‐derived peptides
Moutal, A., Li, W., Wang, Y., Ju, W., Luo, S., Cai, S., François‐Moutal, L., Perez‐Miller, S., Hu, J., Dustrude, E. T., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13737 · Cited by 49
“2 channel antagonists are recommended as first-line treatment for neuropathic pain (Attal et al., 2010; Dowell et al., 2016), calcium current-blocking gabapentinoids inadequately alleviate chronic pain symptoms and often are compromised by numerous and serious side effects (Dworkin et al.”
Background
Repetitive transcranial magnetic stimulation for chronic neuropathic pain in patients with bladder pain syndrome/interstitial cystitis
Cervigni, M., Onesti, E., Ceccanti, M., Gori, M. C., Tartaglia, G., Campagna, G., Panico, G., Vacca, L., Cambieri, C., Libonati, L., et al. (2018) · Neurourology and Urodynamics · doi:10.1002/nau.23718 · Cited by 54
“To date, the most common approach to neuropathic pain is the use of tricyclic antidepressants, pregabalin, gabapentin, opioids, duloxetine, topical lidocaine, and capsaicin patches.(13) Neurostimulation of the sacral or tibial nerves may be offered as fourth-line treatment on account of the ability of such stimulation…”
Background
Pregabalin Vs. Opioids for the Treatment of Neuropathic Cancer Pain: A Prospective, Head‐to‐Head, Randomized, Open‐Label Study
Raptis, E., Vadalouca, A., Stavropoulou, E., Αrgyra, E., Melemeni, A., & Siafaka, I. (2013) · Pain Practice · doi:10.1111/papr.12045 · Cited by 49
Diagnosis and management of neuropathic pain: Review of literature and recommendations of the Polish Association for the Study of Pain and the Polish Neurological Society – Part Two
Szczudlik, A., Dobrogowski, J., Wordliczek, J., Stępień, A., Krajnik, M., Leppert, W., Woroń, J., Przeklasa-Muszyńska, A., Kocot-Kępska, M., Zajączkowska, R., et al. (2014) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2014.11.002 · Cited by 50
Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions
Snedecor, S. J., Sudharshan, L., Cappelleri, J. C., Sadosky, A., Desai, P., Jalundhwala, Y. J., & Botteman, M. F. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12411 · Cited by 48
Liquiritigenin alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model
Chen, L., Chen, W., Qian, X., Fang, Y., & Zhu, N. (2014) · Scientific Reports · doi:10.1038/srep05676 · Cited by 48
P2X3-mediated peripheral sensitization of neuropathic pain in resiniferatoxin-induced neuropathy
Hsieh, Y., Chiang, H., Lue, J., & Hsieh, S. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.02.013 · Cited by 48
Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain
del Águila, M. J. S., Schenk, M., Kern, K., Drost, T., & Steigerwald, I. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.005 · Cited by 49
Clinical practice guidelines for management of neuropathic pain: Expert panel recommendations for South Africa
Chetty, S., Baalbergen, E., Bhigjee, A. I., Kamerman, P. R., Ouma, J., Raath, R., Raff, M., & Salduker, S. (2012) · South African Medical Journal · doi:10.7196/samj.5472 · Cited by 48
Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies
Gurba, K. N., Chaudhry, R., & Haroutounian, S. (2022) · CNS Drugs · doi:10.1007/s40263-022-00914-4 · Cited by 47
Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders
Zayed, M. A., Sultan, S., Alsaab, H. O., Yousof, S. M., Alrefaei, G. I., Alsubhi, N. H., Alkarim, S., Ghamdi, K. S. A., Bagabir, S. A., Jana, A., et al. (2022) · Cells · doi:10.3390/cells11213476 · Cited by 47
Management of painful neuropathies
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00017-5 · Cited by 47
Self-citation
The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use
Baron, R., Allegri, M., Correa‐Illanes, G., Hans, G. H., Serpell, M. G., Mick, G., & Mayoral, V. (2016) · Pain and Therapy · doi:10.1007/s40122-016-0060-3 · Cited by 47
“updated guidelines stated that the 5% lidocaine-medicated plaster may be considered a first-line treatment in the elderly, particularly if there are concerns regarding the CNS side effects of oral medications [13].”
BackgroundMethodInfluentialSelf-citation
Current Diagnosis and Treatment of Painful Small Fiber Neuropathy
Farhad, K. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-1020-1 · Cited by 47
EAN guideline on palliative care of people with severe, progressive multiple sclerosis
Solari, A., Giordano, A., Sastre‐Garriga, J., Köpke, S., Rahn, A. C., Kleiter, I., Aleksovska, K., Battaglia, M. A., Bay, J., Copetti, M., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14248 · Cited by 47
Non‐length‐dependent small fiber neuropathy: Not a matter of stockings and gloves
Gemignani, F., Bellanova, M. F., Saccani, E., & Pavesi, G. (2021) · Muscle & Nerve · doi:10.1002/mus.27379 · Cited by 47
Neuropathic pain in leprosy
Raicher, I., Stump, P., Baccarelli, R., Marciano, L. H. S. C., Ura, S., Virmond, M., Teixeira, M. J., & de Andrade, D. C. (2015) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2015.10.012 · Cited by 46
Neuropathic Pain in Neurologic Disorders: A Narrative Review
Mitsikostas, D. D., Μoka, Ε., Orrillo, E., Aurilio, C., Vadalouca, A., Paladini, A., & Varrassi, G. (2022) · Cureus · doi:10.7759/cureus.22419 · Cited by 53
“Guidelines for neuropathic pain care are issued by the IASP [66-68], the European Federation of Neurological Societies [69-71], the National Institute for Health and Care Excellence (NICE), and the Canadian Pain Society [72,73], among others.”
Method
Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
Kaku, M. C., Vinik, A. I., & Simpson, D. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0609-2 · Cited by 48
Surgical Options after a Failed Neurectomy in Anterior Cutaneous Nerve Entrapment Syndrome
van Assen, T., Boelens, O. B. A., van Eerten, P., Scheltinga, M. R., & Roumen, R. M. H. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2737-2 · Cited by 46
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability
Navez, M. L., Monella, C., Boesl, I., Sommer, D., & Delorme, C. (2015) · Pain and Therapy · doi:10.1007/s40122-015-0034-x · Cited by 46
The reciprocal associations between catastrophizing and pain outcomes in patients being treated for neuropathic pain: a cross-lagged panel analysis study
Racine, M., Moulin, D. E., Nielson, W. R., Morley-Forster, P., Lynch, M. E., Clark, A. J., Stitt, L., GORDON, A. S., Nathan, H., Smyth, C. E., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000594 · Cited by 48
“Neuropathic pain (NeP), which occurs as a result of a lesion or a disease affecting the somatosensory system,(45) is one of the most refractory pain syndromes.(1,18) There is a growing interest in the influence of psychological factors such as catastrophizing on NeP outcomes.”
Background
Pharmacological treatment of trigeminal neuralgia
Stefano, G. D., & Truini, A. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1370375 · Cited by 47
“OXC, a keto-analog of CBZ rapidly converted into its pharmacologically active 10-monohydroxy metabolite, should be preferred for the better tolerability and the decreased potential for drugs interactions [17,81,82].”
Background
Inherited Neuropathies
Schenone, A. E., Nobbio, L., Bragadin, M. M., Ursino, G., & Grandis, M. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0115-z · Cited by 46
Effects of sub‐perception threshold spinal cord stimulation in neuropathic pain: A randomized controlled double‐blind crossover study
Wolter, T., Kiemen, A., Porzelius, C., & Kaube, H. (2011) · European Journal of Pain · doi:10.1002/j.1532-2149.2011.00060.x · Cited by 46
Adherence of French GPs to Chronic Neuropathic Pain Clinical Guidelines: Results of a Cross-Sectional, Randomized, “e” Case-Vignette Survey
Martinez, V., Attal, N., Vanzo, B., Vicaut, E., Gautier, J. M., Bouhassira, D., & Lantéri-Minet, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093855 · Cited by 45
Self-citation
Individualized Pharmacological Treatment of Neuropathic Pain
Helfert, S. M., Reimer, M., Höper, J., & Baron, R. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.19 · Cited by 45
Self-citation
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain
Treede, R., Wagner, T., Kern, K., Husstedt, I., Arendt, G., Birklein, F., Cegla, T. H., Freynhagen, R., Gockel, H.-H., Heskamp, M. ‐. S., et al. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.781019 · Cited by 45
Self-citation
Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study
Gálvez, R., Schäfer, M., Hans, G. H., Falke, D., & Steigerwald, I. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0015-6 · Cited by 45
Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury
Snedecor, S. J., Sudharshan, L., Cappelleri, Sadosky, A., Desai, Jalundhwala, & Botteman (2013) · Journal of Pain Research · doi:10.2147/jpr.s45966 · Cited by 45
Systematic review and recommendations for nonodontogenic toothache
Yatani, H., Komiyama, O., Matsuka, Y., Wajima, K., Muraoka, W., Ikawa, M., Sakamoto, E., Laat, A. D., & Heir, G. M. (2014) · Journal of Oral Rehabilitation · doi:10.1111/joor.12208 · Cited by 46
Acupuncture for the treatment of severe acute pain in Herpes Zoster: results of a nested, open-label, randomized trial in the VZV Pain Study
Ursini, T., Tontodonati, M., Manzoli, L., Polilli, E., Rebuzzi, C., Congedo, G., Profio, S. D., Toro, P. M., Consorte, A., Placido, G., et al. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-46 · Cited by 45
The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence
de León-Casasola, O. A., & Mayoral, V. (2016) · Journal of Pain Research · doi:10.2147/jpr.s99231 · Cited by 45
Neuropathic Pain
Attal, N. (2012) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000411564.41709.2d · Cited by 45
Self-citation
Neuropathic pain in patients with rotator cuff tears
Karasugi, T., Ide, J., Kitamura, T., Okamoto, N., Tokunaga, T., & Mizuta, H. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1311-5 · Cited by 45
Neuropathic Pain After Breast Cancer Treatment: Characterization and Risk Factors
Pereira, S., Fontes, F., Sonin, T., Dias, T., Fragoso, M., Castro‐Lopes, J. M., & Lunet, N. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2017.04.011 · Cited by 45
Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2
Pan, C., Wang, C., Zhang, L., Song, L., Chen, Y., Liu, B., Liu, W., Hu, L., & Pan, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1182-9 · Cited by 46
“Effective treatment, however, is hampered by an incomplete understanding of neuropathic pain’s pathogenesis [1].”
Duloxetine and pregabalin in neuropathic pain of lung cancer patients
Gül, Ş. K., Tepetam, H., & Gül, H. L. (2020) · Brain and Behavior · doi:10.1002/brb3.1527 · Cited by 45
“…month 3. month VAS SCORES pregabalin duloxe ne TA B L E 1 Demographic variables Groups Number of patients Gender (F/M) Age (mean) Group 1 (pregabalin) 20 7/13 57.45 (33–81) Group 2 (duloxetine) 22 7/15 58.27 (37–81) efficacy as achieved in the literature (Attal et al., 2010; Namaka et al., 2004).”
BackgroundMethodInfluential
Understanding chronic ocular surface pain: An unmet need for targeted drug therapy
Galor, A., Hamrah, P., Haque, S., Attal, N., & Labétoulle, M. (2022) · The Ocular Surface · doi:10.1016/j.jtos.2022.08.005 · Cited by 46
Self-citation
Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options
Mallick‐Searle, T., & Adler, J. A. (2024) · Journal of Pain Research · doi:10.2147/jpr.s442595 · Cited by 49
Early evoked pain or dysesthesia is a predictor of central poststroke pain
Klit, H., Hansen, A. P., Marcussen, N. S., Finnerup, N. B., & Jensen, T. S. (2014) · Pain · doi:10.1016/j.pain.2014.09.037 · Cited by 44
Self-citation
Spinal Cord Transection-Induced Allodynia in Rats – Behavioral, Physiopathological and Pharmacological Characterization
M’Dahoma, S., Bourgoin, S., Kayser, V., Barthélémy, S., Chevarin, C., Chali, F., Orsal, D., & Hamon, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102027 · Cited by 50
Topical phenytoin for the treatment of neuropathic pain
Kopsky, D. J., & Hesselink, J. M. K. (2017) · Journal of Pain Research · doi:10.2147/jpr.s129749 · Cited by 44
“Guidelines recommend lidocaine patch in elderly as a first-line treatment, especially if there are concerns about the CNS side effects of oral medications.(10) One study shows that topical lidocaine gives no rise to cognitive impairment in elderly, whereas oral analgesics do.”
Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging
Wanigasekera, V., Wartolowska, K., Huggins, J. P., Duff, E. P., Vennart, W., Whitlock, M., Massat, N. J., Pauer, L., Rogers, P. D., Hoggart, B., et al. (2017) · British Journal of Anaesthesia · doi:10.1016/j.bja.2017.11.064 · Cited by 46
“Interestingly, in recent neuropathic pain treatment guidelines, tramadol was not among the recommended treatments for post-traumatic neuropathic pain.(34) We also note that, when compared with placebo, tramadol significantly reduced spontaneously reported PPI and DPS7 scores but not evoked pain reports.”
Result
Patient and economic burdens of postherpetic neuralgia in China
Yu, S., Fan, B., Yang, F., DiBonaventura, M., Chen, Y.-X., Li, R., King-Concialdi, K., Kudel, I., Hlavacek, P. R., Hopps, M., et al. (2019) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s203920 · Cited by 44
“These pharmacologic treatments appeared to be consistent with guidelines for PHN management, with the predominant use of anticonvulsants followed by tricyclic antidepressants; both classes are considered first-line treatment.(5,6,53)”
Background
Treatment of Neuropathic Pain
Mendlik, M. T., & Uritsky, T. J. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0381-2 · Cited by 44
Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018
Gorfinkel, L., Hasin, D. S., Saxon, A. J., Wall, M. M., Martins, S. S., Cerdá, M., Keyes, K. M., Fink, D. S., Keyhani, S., Maynard, C. C., et al. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.01.006 · Cited by 47
World Health Organization essential medicines lists
Kamerman, P. R., Wadley, A. L., Davis, K. D., Hietaharju, A., Jain, P. N., Köpf, A., Meyer, A.-C. L., Raja, S. N., Rice, A. S. C., Smith, B. H., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460356.94374.a1 · Cited by 43
A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs
Smithburger, P. L., Buckley, M. S., Culver, M. A., Sokol, S. S., Lat, I., Handler, S. M., Kirisci, L., & Kane‐Gill, S. L. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001022 · Cited by 43
Generalized Anxiety Disorder and Pain
Bandelow, B. (2015) · Modern trends in psychiatry · doi:10.1159/000435939 · Cited by 43
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain
Webster, L. R., Peppin, J. F., Murphy, F. T., Lu, B., Tobias, J. K., & Vanhove, G. F. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.04.010 · Cited by 43
The Role of Sodium Channels in Painful Diabetic and Idiopathic Neuropathy
On behalf of the PROPANE Study group, Lauria, G., Ziegler, D., Malik, R. A., Merkies, I. S. J., Waxman, S. G., & Faber, C. G. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0538-5 · Cited by 43
Treatment of Neuropathic Pain
Jefferies, K. A. (2010) · Seminars in Neurology · doi:10.1055/s-0030-1267286 · Cited by 43
Concomitant medication among persistent opioid users with chronic non‐malignant pain
Mellbye, A., Svendsen, K., Borchgrevink, P. C., Skurtveit, S. O., & Fredheim, O. M. S. (2012) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2012.02766.x · Cited by 42
Treating pain in multiple sclerosis
Truini, A., Galeotti, F., & Cruccu, G. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.607162 · Cited by 42
Self-citation
Cancer-related neuropathic pain in out-patient oncology clinics: a European survey
Garzón-Rodríguez, C., Lyras, L., Gayoso, L. O., Sepúlveda-Sánchez, J. M., Samantas, E., Pelzer, U., Bowen, S., van Litsenburg, C., & Strand, M. (2013) · BMC Palliative Care · doi:10.1186/1472-684x-12-41 · Cited by 42
Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study
Fénelon, M., Quinque, E., Arrivé, É., Catros, S., & Fricain, J. (2017) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2017.03.032 · Cited by 42
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Azmi, S., Elhadd, K. T., Nelson, A., Chapman, A., Bowling, F. L., Perumbalath, A., Lim, J. Z. M., Marshall, A. G., Malik, R. A., & Alam, U. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0550-x · Cited by 48
Nutritional Supplements for the Treatment of Neuropathic Pain
Abdelrahman, K. M., & Hackshaw, K. V. (2021) · Biomedicines · doi:10.3390/biomedicines9060674 · Cited by 42
“Several pharmacologic therapies have been demonstrated to be effective in neuropathic pain, including tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, and the anticonvulsants gabapentin and pregabalin as first-line treatment options in clinical practice [3,6,7].”
Background
Vortioxetine versus other antidepressants in the treatment of burning mouth syndrome: An open‐label randomized trial
Adamo, D., Pecoraro, G., Coppola, N., Calabria, E., Aria, M., & Mignogna, M. D. (2020) · Oral Diseases · doi:10.1111/odi.13602 · Cited by 43
Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression
Hache, G., Guiard, B. P., Dantec, Y. L., Orvoën, S., David, D. J. P., Gardier, A. M., & Coudoré, F. (2012) · Neuroreport · doi:10.1097/wnr.0b013e328353d70a · Cited by 47
Opioid Use in the Management of Diabetic Peripheral Neuropathy (DPN) in a Large Commercially Insured Population
Patil, P. R., Wolfe, J., Said, Q., Thomas, J., & Martin, B. C. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000124 · Cited by 40
The Efficacy of Morphine, Pregabalin, Gabapentin, and Duloxetine on Mechanical Allodynia Is Different from That on Neuroma Pain in the Rat Neuropathic Pain Model
Miyazaki, R., & Yamamoto, T. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31824f94ca · Cited by 41
A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: Efficacy and tolerability in a double-blind, randomized, controlled clinical trial
Sandercock, D., Cramer, M., Biton, V., & Cowles, V. E. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.03.010 · Cited by 41
Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy
Dworkin, R. H., Turk, D. C., Basch, E., Berger, A. M., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Markman, J. D., et al. (2011) · Pain · doi:10.1016/j.pain.2011.02.026 · Cited by 41
Neuropathic Pain Components in Patients with Lumbar Spinal Stenosis
Park, S.-Y., An, H. S., Moon, S. H., Lee, H., Suh, S. W., Chen, D., & Jeon, J. H. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.4.1044 · Cited by 42
Management of Pain in Complex Nerve Injuries
Davis, G., & Curtin, C. M. (2016) · Hand Clinics · doi:10.1016/j.hcl.2015.12.011 · Cited by 41
Nonpharmacological therapies for central poststroke pain
Xu, X., Luo, H., Rong, B., Zheng, X.-M., Wang, F.-T., Zhang, S., & Li, Z. (2020) · Medicine · doi:10.1097/md.0000000000022611 · Cited by 41
Antiallodynic Effect of Herbal Medicine Yokukansan on Peripheral Neuropathy in Rats with Chronic Constriction Injury
Suzuki, Y., Mitsuhata, H., Yuzurihara, M., & Kase, Y. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/953459 · Cited by 41
Evidence-based approach to manage persistent wound-related pain
Woo, K. Y., Abbott, L. K., & Librach, S. L. (2013) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e32835d7ed2 · Cited by 41
Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial)
Bačkonja, M., Williams, L. J., Miao, X., Katz, N. P., & Chen, C. (2017) · Pain · doi:10.1097/j.pain.0000000000000983 · Cited by 40
“Patients also had objective, documented evidence of PLSR, as evidenced by one of the following assessments, correlating with their symptomatology of PLSR: (1) electromyographic evidence of fourth or fifth lumbar root (L4/ L5)/first sacral root (S1) irritation on the affected side; or (2) imaging (magnetic resonance im…”
Method
Light‐emitting diode therapy induces analgesia and decreases spinal cord and sciatic nerve tumour necrosis factor‐α levels after sciatic nerve crush in mice
Cidral‐Filho, F. J., Martins, D. F., Moré, A. O. O., Mazzardo‐Martins, L., da Silva, M. D., Cargnin‐Ferreira, E., & Santos, A. R. S. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00280.x · Cited by 40
Measurement properties of painDETECT by average pain severity
Sadosky, A., Cappelleri, J. C., Bienen, E. J., & Koduru, V. (2014) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s68997 · Cited by 40
High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know
Üçeyler, N., & Sommer, C. (2014) · Pain and Therapy · doi:10.1007/s40122-014-0027-1 · Cited by 40
Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy
Koeppen, S. (2014) · Oncology Research and Treatment · doi:10.1159/000365534 · Cited by 42
Drug Combinations in the Treatment of Neuropathic Pain
Eisenberg, E., & Suzan, E. (2014) · Current Pain and Headache Reports · doi:10.1007/s11916-014-0463-y · Cited by 40
Neuropathic pain
Hurley, R. W., Adams, M. C. B., & Benzon, H. T. (2013) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e328363b4bf · Cited by 40
Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain
Simpson, R. W., & Wlodarczyk, J. H. (2016) · Diabetes Care · doi:10.2337/dc16-0123 · Cited by 40
An update on the pharmacologic management and treatment of neuropathic pain
Wright, M. E., & Rizzolo, D. (2017) · JAAPA · doi:10.1097/01.jaa.0000512228.23432.f7 · Cited by 40
Capsaicin, its clinical significance in patients with painful diabetic neuropathy
Dludla, P. V., Nkambule, B. B., Cirilli, I., Marcheggiani, F., Mabhida, S. E., Ziqubu, K., Ntamo, Y., Jack, B. U., Nyambuya, T. M., Hanser, S., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113439 · Cited by 40

Authors: Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T.
Affiliations: Inserm (FR)
Sapienza University of Rome (IT)
University Hospital Schleswig-Holstein (DE)
Helsinki University Hospital (FI)
Karolinska University Hospital (SE)
Aarhus University Hospital (DK)
University of Liverpool (GB)
Corresponding author: Attal, N.
ORCID: Attal, N.
Cruccu, G.
Baron, R.
Haanpää, M.
Hansson, P.
Jensen, T. S.
Nurmikko, T.
Venue: European Journal of Neurology
Publisher: Wiley
Published: 2010-04-07
Volume: 17
Issue: 9
Pages: 1113
ISSN: 1351-5101 (ISSN-L)
1468-1331
DOI: 10.1111/j.1468-1331.2010.02999.x
OpenAlex: W2128412489
Cited by: 1,873
References: 236
Citations by year: 2026: 39 · 2025: 59 · 2024: 85 · 2023: 81 · 2022: 91 · 2021: 128 · 2020: 134 · 2019: 112 · 2018: 102 · 2017: 151 · 2016: 136 · 2015: 152 · 2014: 185 · 2013: 185 · 2012: 121
FWCI: 89.44
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: European Journal of Neurology (publishedVersion)
PubMed (publishedVersion)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics: Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords: neuropathic pain, pharmacotherapy, diabetic polyneuropathy, postherpetic neuralgia, trigeminal neuralgia, chronic radiculopathy, HIV neuropathy, tricyclic antidepressants, pregabalin, gabapentin, tramadol, opioids, duloxetine, venlafaxine, topical lidocaine, capsaicin patch, combination therapy, treatment efficacy
MeSH terms: Gabapentin, Amines, Analgesia, Analgesics, Analgesics, Opioid, Antidepressive Agents, Tricyclic, Cyclohexanecarboxylic Acids, Drug Therapy, Combination, Europe, gamma-Aminobutyric Acid, Humans, Neuralgia, Peripheral Nervous System Diseases, Randomized Controlled Trials as Topic, Treatment Outcome, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks